Nitto Avecia Pharma Services
News & Events

Avecia Announces Opening of Cambridge, MA Office

February 1st, 2018 by admin

CAMBRIDGE, MA – Nitto Denko Avecia, Inc. (Avecia), a leader in oligonucleotide API (active pharmaceutical ingredient) manufacturing, announced today the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible...
Read Full Story »

Posted in: Press Release,

Nitto Avecia Pharma Services Appoints Raymond Kaczmarek as President

January 15th, 2018 by admin

IRVINE, CA – Nitto Avecia Pharma Services, Inc. (Avecia Pharma), a leading CGMP contract development and manufacturing organization (CDMO), announced today that it has appointed Raymond Kaczmarek to the position of President. Mr. Kaczmarek will have full P&L responsibility for the entire organization....
Read Full Story »

Posted in: Press Release,

Nitto Avecia Completes Multiple Successful Oligonucleotide Manufacturing Synthesis Runs at 1.6 Mol Scale

November 7th, 2017 by admin

MILFORD, MA – Nitto Avecia, Inc. (Avecia) announced today the successful completion of the first synthesis runs at the 1.6 Mol scale which is believed to be the largest synthesis scale ever executed for oligonucleotide API (active pharmaceutical ingredients) at its new oligonucleotide manufacturing...
Read Full Story »

Posted in: Press Release,

Nitto Denko Avecia Announces Opening of Manufacturing Expansion

July 26th, 2017 by admin

Nitto Denko Avecia Inc. (Avecia) has announced the opening of its new oligonucleotide API (active pharmaceutical ingredients) manufacturing facility in Milford, MA. The opening will commence with a ribbon cutting ceremony in August 2017 onsite at the Milford, MA facility. The ceremony will open with...
Read Full Story »

Posted in: Company News,

Nitto Avecia Announces Multiple Oligonucleotide Expansions

November 14th, 2016 by admin

MILFORD, MA – Nitto Avecia Inc. (Avecia) today released its progress in expanding the company’s analytical development and oligonucleotide manufacturing capacities. The announcement signals the continuation of Avecia’s robust growth strategy to significantly increase its oligonucleotide drug substance...
Read Full Story »

Posted in: Press Release,

Nitto Denko Avecia, Inc. Acquires the Businesses of Irvine Pharmaceutical Services & Avrio Biopharmaceuticals

October 11th, 2016 by admin

MILFORD, MA – Nitto Denko Avecia, Inc. (Avecia), today announced it has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio Biopharmaceuticals (Avrio), both located in Irvine, CA. Irvine is a leading analytical development services provider...
Read Full Story »

Posted in: Press Release,